academic article

• Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study..  The American journal of drug and alcohol abuse.  :1-10. 2016
• The efficacy of attention bias modification therapy in cocaine use disorders..  The American journal of drug and alcohol abuse.  :1-10. 2016
• Dose specific effects of olanzapine in the treatment of alcohol dependence..  Psychopharmacology.  232:1261-1268. 2015
• Classic hallucinogens in the treatment of addictions..  Progress in neuro-psychopharmacology & biological psychiatry.  :-. 2015
• Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study..  Journal of psychopharmacology (Oxford, England).  29:289-299. 2015
• Cognitive control network function in alcohol use disorder before and during treatment with Lorazepam..  Substance use & misuse.  50:40-52. 2015
• Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial..  JAMA internal medicine.  174:1736-1745. 2014
• Identifying patients with problematic drug use in the emergency department: results of a multisite study..  Annals of emergency medicine.  64:516-525. 2014
• Alcohol, tobacco, and drug use among emergency department patients. 2014
• 12-step facilitation for the dually diagnosed: a randomized clinical trial. 2014
• Cognitive control in alcohol use disorder: deficits and clinical relevance..  Reviews in the neurosciences.  25:1-24. 2014
• Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants..  Addictive behaviors.  38:2568-2574. 2013
• Diffusion tensor imaging of white matter networks in individuals with current and remitted alcohol use disorders and comorbid conditions. 2013
• Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin..  Current drug abuse reviews.  6:17-29. 2013
• Test-retest reliability of self-report measures in a dually diagnosed sample..  Substance use & misuse.  48:99-105. 2013
• Health status of ayahuasca users..  Drug testing and analysis.  4:601-609. 2012
• Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses..  Drug testing and analysis.  4:543-555. 2012
• Community Reinforcement and Family Training: a pilot comparison of group and self-directed delivery. 2012
• Compensation effects on clinical trial data collection in opioid-dependent young adults..  The American journal of drug and alcohol abuse.  38:81-86. 2012
• Study design to examine the potential role of assessment reactivity in the Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) protocol. 2012
• American Indian methamphetamine and other drug use in the Southwestern United States..  Cultural diversity & ethnic minority psychology.  17:366-376. 2011
• Adolescent substance abuse: the effects of alcohol and marijuana on neuropsychological performance..  Alcoholism, clinical and experimental research.  35:39-46. 2011
• Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED)..  The American journal of drug and alcohol abuse.  37:417-425. 2011
• Effects of buprenorphine and hepatitis C on liver enzymes in adolescents and young adults..  Journal of addiction medicine.  4:211-216. 2010
• Ethics in substance use disorder treatment..  The Psychiatric clinics of North America.  32:283-297. 2009
• Pharmacological research on addictions: a framework for ethical and policy considerations..  Journal of psychoactive drugs.  41:49-60. 2009
• Effects of alcoholism typology on response to naltrexone in the COMBINE study..  Alcoholism, clinical and experimental research.  33:10-18. 2009
• Response: anticipating new medications. 2008
• Individual and contextual factors that influence AA affiliation and outcomes..  Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism.  18:413-433. 2008
• 12-step approaches for the dually diagnosed: mechanisms of change..  Alcoholism, clinical and experimental research.  31:64s-66s. 2007
• Development of a bibliography on religion, spirituality and addictions..  Drug and alcohol review.  26:389-395. 2007
• Spirituality and addiction..  Southern medical journal.  100:433-436. 2007
• Examining the effects of alcoholism typology and AA attendance on self-efficacy as a mechanism of change..  Journal of studies on alcohol.  67:562-567. 2006
• Is alcoholism typology a predictor of both Alcoholics Anonymous affiliation and disaffiliation after treatment? 2006
• The role of twelve-step approaches in dual diagnosis treatment and recovery..  The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions.  15:50-60. 2006
• Specialized 12-step programs and 12-step facilitation for the dually diagnosed..  Community mental health journal.  41:7-20. 2005
• Pharmacotherapy for pregnant women with addictions..  American journal of obstetrics and gynecology.  191:1885-1897. 2004
• Olanzapine versus placebo in the treatment of borderline personality disorder..  The Journal of clinical psychiatry.  65:104-109. 2004
• Pharmacologic treatments for women with addictions..  Obstetrics and gynecology clinics of North America.  30:523-544. 2003
• Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatients..  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.  28:527-529. 2003
• Examining an affect regulation model of substance abuse in schizophrenia. The role of traits and coping..  The Journal of nervous and mental disease.  187:72-79. 1999